Challenges and controversies in resectable non-small cell lung cancer: a clinician’s perspective
2024 · The Lancet Regional Health - Europe · 33 citations
https://doi.org/10.1016/j.lanepe.2024.100841
R
Ronald Damhuis
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
214
Papers
5.6K
Citations
36
h-index
86
i10-index
Ronald Damhuis is an academic researcher from Netherlands Comprehensive Cancer Organisation. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Diagnosis and Treatment & Lung Cancer Research Studies. The author has an h-index of 36, co-authored 182 publications.
ORCID: 0000-0001-7248-7047Papers by this author
worksMutation-tailored treatment selection in non-small cell lung cancer patients in daily clinical practice
2022 · Lung Cancer · 27 citations
https://doi.org/10.1016/j.lungcan.2022.04.001
Stage I non-small cell lung cancer: Treatment modalities, Dutch daily practice and future perspectives
2021 · Cancer Treatment and Research Communications · 13 citations
https://doi.org/10.1016/j.ctarc.2021.100404
Identification of Defined Molecular Subgroups on the Basis of Immunohistochemical Analyses and Potential Therapeutic Vulnerabilities of Pulmonary Carcinoids
2024 · Journal of Thoracic Oncology · 13 citations
https://doi.org/10.1016/j.jtho.2024.11.018
Real-world treatment patterns and survival of patients with ROS1 rearranged stage IV non-squamous NSCLC in the Netherlands
2023 · Lung Cancer · 12 citations
https://doi.org/10.1016/j.lungcan.2023.107253
Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries
2018 · BMC Cancer · 10 citations
https://doi.org/10.1186/s12885-018-5009-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat